[PDF][PDF] Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head
Journal of clinical oncology, 2008•Citeseer
Preoperative Gemcitabine and Cisplatin Followed by Gemcitabine-Based Chemoradiation for
Resectable Adenocarcinoma of the Pancrea Page 1 Preoperative Gemcitabine and Cisplatin
Followed by Gemcitabine-Based Chemoradiation for Resectable Adenocarcinoma of the
Pancreatic Head Gauri R. Varadhachary, Robert A. Wolff, Christopher H. Crane, Charlotte C.
Sun, Jeffrey E. Lee, Peter WT Pisters, Jean-Nicolas Vauthey, Eddie Abdalla, Huamin Wang,
Gregg A. Staerkel, Jeffrey H. Lee, William A. Ross, Eric P. Tamm, Priya R. Bhosale, Sunil …
Resectable Adenocarcinoma of the Pancrea Page 1 Preoperative Gemcitabine and Cisplatin
Followed by Gemcitabine-Based Chemoradiation for Resectable Adenocarcinoma of the
Pancreatic Head Gauri R. Varadhachary, Robert A. Wolff, Christopher H. Crane, Charlotte C.
Sun, Jeffrey E. Lee, Peter WT Pisters, Jean-Nicolas Vauthey, Eddie Abdalla, Huamin Wang,
Gregg A. Staerkel, Jeffrey H. Lee, William A. Ross, Eric P. Tamm, Priya R. Bhosale, Sunil …
Purpose
We conducted a phase II trial of preoperative gemcitabine and cisplatin chemotherapy in addition to chemoradiation (Gem-Cis-XRT) and pancreaticoduodenectomy (PD) for patients with stage I/II pancreatic adenocarcinoma.
Citeseer
